The Washington Post is reporting that the results of a clinical trial for the pill daraxonrasib have been released, offering new hope for treating pancreatic cancer. It said the drug kept patients alive for twice as long as those receiving regular chemotherapy. The newspaper noted that these highly anticipated results could mark a new era in fighting the highly lethal disease.
